2025-02-28
2024-02-08
| Summary | |
|---|---|
| Cancer Type | Acute Myeloid Leukemia |
| Mutations | FLT3-D835H; NPM1-W288Cfs*12; DNMT3A-R882H; IDH1-R132H |
| Stage | Unavailable |
| Treatment History | Allogeneic HSCT | Sorafenib | Hydroxyurea | Decitabine |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy